Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of ReShape Lifesciences Inc (NASDAQ: RSLS) was $1.03 for the day, down -6.36% from the previous closing price of $1.10. In other words, the price has decreased by -$6.36 from its previous closing price. On the day, 0.68 million shares were traded.
Ratios:
Our analysis of RSLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.05.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 31 ’24 when STANKOVICH THOMAS sold 48 shares for $0.25 per share. The transaction valued at 12 led to the insider holds 22,777 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.09 while its Price-to-Book (P/B) ratio in mrq is 0.49.
Stock Price History:
Over the past 52 weeks, RSLS has reached a high of $29.00, while it has fallen to a 52-week low of $1.01. The 50-Day Moving Average of the stock is -71.17%, while the 200-Day Moving Average is calculated to be -86.37%.
Shares Statistics:
A total of 0.70M shares are outstanding, with a floating share count of 0.13M. Insiders hold about 81.88% of the company’s shares, while institutions hold 4.57% stake in the company.
